FDA Adverse Event Injury Summary report: N

GORE DRYSEAL SHEATH

MDR report key: 2020158 · Received March 7, 2011

Report

Report Number
2017233-2011-00104
Event Type
Injury
Date Received
March 7, 2011
Date of Event
February 17, 2011
Report Date
March 5, 2011
Manufacturer
W.L. GORE & ASSOCIATES, INC.
Product Code
DYB
PMA / PMN Number
K093791
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EVAL, METHOD: A REVIEW OF THE MFG PAPERWORK HAS BEEN CONDUCTED. RESULTS: THE REVIEW OF THE MFG PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS.

Description of Event or Problem · 1

ON (B)(6) 2011, THE PT UNDERWENT TREATMENT FOR AN ABDOMINAL AORTIC ANEURYSM WITH GORE EXCLUDER AAA ENDOPROSTHESIS. IT WAS REPORTED THAT THE DEVICES WERE DEPLOYED WITH NO ISSUE. WHEN THE PHYSICIAN REPORTEDLY RETRACTED THE GORE DRYSEAL SHEATH TO PERFORM FINAL ANGIOGRAPHY, THE PT'S LEFT ILIAC ARTERY RUPTURED. IT WAS REPORTEDLY DETERMINED THAT THE SHEATH COMPRESSED WHILE IN THE ILIAC ARTERY, CREATING A CHANNEL THAT FORMED A SHARP EDGE AT THE RADIOPAQUE MARKER. AS REPORTED, THE SHARP EDGE AT THE RADIOPAQUE MARKER SUBSEQUENTLY TORE THE ILIAC ARTERY. ADD'L GORE EXCLUDER AAA ENDOPROSTHESES WERE REPORTEDLY IMPLANTED TO EXTEND PAST THE HYPOGASTRIC ARTERY AND RUPTURED AREA, AND THE PT RECEIVED 2 UNITS OF BLOOD. FINAL ANGIOGRAPHY SHOWED RESOLUTION OF THE RUPTURE, AND THE PT TOLERATED THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE DRYSEAL SHEATH DYB/INTRODUCER, CATHETER DYB W.L. GORE & ASSOCIATES, INC. WLG401 8340593

Patients

Seq Age Sex Outcome Treatment
1 78 YR Hospitalization| R ASPIRIN| ACETAMIN CQD| TRIAMTERINE| PRAVASTATIN| PLAVIX